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Introduction1
Perhaps the greatest threat to woman's fertility is
advancing age. Many women are now choosing to
delay marriage until they are much older and con-
sequently, many are attempting pregnancy in their
mid to late 30s and early 40s. Unfortunately, the
biological clock has not changed to coincide with the
evolution of our societal values and fertility for
women is greatest in the late teens and early 20s.
There is no treatment that can "turn back the clock"
on a woman's ovaries (1, 2). A large part of this
population will be infertile by the time they consider
to conceive, mainly because of a decreasing ovarian
reserve and low oocyte quality resulting from age.
Aging oocytes have been widely suggested to be the
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major cause for the decline in fertility (3).
Many physicians use fertility medications to in-
crease the chance of pregnancy. Fertility medications
increase the number of ova that develop in a given
month, and enhance the chance that at least one of
them might be fertilized and develop into a preg-
nancy. Although fertility medications seem to offer
some hope, the pregnancy rates are generally poor.
Female age and fertility
Women are born with a lifetime supply of oocytes
and during each month of a natural cycle one oocyte
develops in the dominant follicle, and undergoes ovu-
lation. This development is initiated and supported by
follicle stimulating hormone (FSH). At the same time,
a group of smaller unselected follicles become atretic
and are no longer capable of reaching ovulation. As
women age, the number of remaining eggs declines,
furthermore, those that are available may demonstrate
a decrease in egg quality. Aging of the ovary is cha-
racterized by a reduction in the number of primordial
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follicles from 1-2 million at birth to only 250 000 at
menarche and very few by the time of the meno-
pause. The size of the original pool and the rate of
loss are genetically determined with a strong familial
tendency transmitted through the familial line. The
rate of loss accelerates from the age of approximately
37 years and precedes the true menopause by 10-12
years (4, 5).
Female age is very important in consideration of
probability for achieving pregnancy. The real issue is
egg quantity and quality, which translates to embryo
quality after fertilization. Increased infertility with
ageing is a well documented problem and very appa-
rent in modern society. As women wait longer to
have children, a higher percentage of couples have
fertility problems because of the quality of the oocy-
tes, and other issues that affect fertility. As women
increasingly delay childbearing, our society has done
a very poor job of educating people about the decline
in female fertility with increasing age (6). Too many
couples learn about the impact of age when it could
already be too late for them. If they had tried to have
a baby sooner, they could have built the family. The
American Society for Reproduction Medicine said it
well: "As women delay childbearing there is now an
unrealistic expectation that medical science can undo
the effects of aging" (7).
Many people are not aware of the decline in
fertility as the age of the female partner increases:
There is a slow decline in pregnancy rates in the early
30?s. This decline is more substantial in the late 30?s
and early 40.
A study published in 1957 examined the relation-
ship between the age of the female partner and fer-
tility. This study found that:
? By age 30, 7% of couples were infertile
? By age 35, 11% of couples were infertile
? By age 40 and 45, 33% and 87% of couples
were infertile, respectively (8).
For several reasons, infertility rates are even
higher in the general population in the U.S. today
than for the population studied by Tietze in the
1950s. The available evidence indicates that the age
related decline in female fertility can be attributed to
progressive follicular depletion and a high incidence
of abnormalities in aging oocytes such as aneuploidy
resulting from disordered regulatory mechanisms go-
verning meiotic spindle formation and function (9-12).
Aging does not appear to have any significant
adverse effect on the uterus. Although the prevalence
of benign uterine pathologies (leiomyomas, endomet-
rial polyps, adenomyosis) increases with aging (13-
15), evidence exists to indicate it has much overall
impact on fertility in women (16-19). Age also does
not appear to adversely affect endometrial develop-
ment or function in response to steroid stimulation
(20).
Perhaps the strongest evidence comes from com-
paring outcomes in non donor and donor egg IVF
cycles. Whereas earlier studies suggested that donor
egg IVF pregnancy and delivery rates decreased mo-
destly with the increasing age of the recipient (21-23)
more recent data clearly refute those conclusions (24-
26). Live birth rates declined progressively with
increasing age for nondonor egg cycles. In contrast,
live birth per transfer rate in donor egg IVF cycles
averaged 43% overall, and did not vary significantly
with age of the recipient. Live birth rates in donor
egg IVF cycles relate to the age of the donor, rather
than the recipient (27).
Female age and miscarriage
Numerous studies have documented the increased
risk of miscarriage as women get older. Most of the
increased risk for miscarriage in older women is due
to the increase in chromosomal abnormalities in their
eggs. This is also the main reason for the decline in
overall fertility with increasing female age (9-12, 28-
30).
The meiotic spindle is a critical component of the
egg that is involved in organizing the chromosome
pairs so that a proper division of the pairs can occur
as the egg is developing. An abnormal spindle can
predispose to development of chromosomally abnor-
mal eggs.
In one study, 17% of the eggs from women 20-25
years old were found to have an abnormal spindle
appearance and at least one chromosome displaced
from proper alignment. In contrast, 79% of the eggs
studied from women 40-45 years old were found to
have an abnormal spindle appearance and at least one
chromosome displaced from proper alignment (29).
This study illustrates how chromosomally abnormal
eggs (and therefore, embryos) are produced more
often in older women. When the chromosomes line
up properly in a straight line on the spindle apparatus
in the egg, the division process would be expected to
proceed normally so that the egg would end up with
its proper complement of 23 chromosomes. However,
with a disordered arrangement on an abnormal spind-
le, the division could easily be uneven – resulting in
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Table1: Pregnancy loss according to maternal age
Maternal age (year) Pregnancy loss rate
< 30 5%
30 – 34 8%
35 - 39 16%
40 - 41 30%
42 - 43 40%
44 - 46 60%
an unbalanced chromosomal situation in the egg.
Therefore as women get older, the incidence of chro-
mosomally abnormal eggs increases dramatically.
This results in lower chances for getting pregnant, as
well as increased risk for miscarriage (Table 1).
When mothers are 35 or older, amniocentesis is
recommended because of the increased risk of a
chromosomally abnormal child (e.g. Down syndro-
me).
Female age and IVF success rate
Many aged women are pursuing fertility treat-
ments and are undergoing assisted reproductive tech-
niques (ARTs). For many older women, their single
best chance to achieve pregnancy is by undergoing In
Vitro Fertilization (IVF) because every step along the
conception pathway is maximized. Whereas, the
number of remaining ovarian follicles steadily declines
with increasing age, more rapidly after approximately
age 38, observations in stimulated cycles suggest that
aging follicles also become progressively less sen-
sitive to gonadotropin stimulation. As age increases,
the total dose and duration of treatment required to
stimulate multiple follicular development increase.
The rate at which estradiol levels rise and the peak
concentration achieved decrease, reflecting the sma-
ller cohort of follicles that can be recruited to respond
(31). Success rates achieved with ART also decline
as age increases. The number of oocytes retrieved and
embryos available are lower, embryo fragmentation
rates are higher, and implantation rates are lower in
older women (32, 33). Although pregnancy rates
have steadily increased over the past 15 years for
women in all age groups, age is the single most
important factor affecting the probability of success
with ART. Pregnancy and live birth rates by age for
ART cycles using fresh, non donor eggs or embryos
vary little for women younger than age 32 but
thereafter steadily decrease in an almost linear
fashion as age increases. According to the 1999 ART
Success Rates, live birth rates per cycles were 32.2%
in women under 35, 26.2% in women aged 35 – 37,
18.5% in women aged 38 – 40, 9.7% in women aged
41 – 42, and approximately 5% in women 43 and
older (34).
Age is one issue, but the real fertility issue is egg
quality and quantity and not the number in a woman's
age. A woman can be 45 years old with exceptionally
good quality eggs and still be fertile (which is rare at
that age), or she can be 25 years old with very poor
quality eggs and be infertile. These are extreme
examples, but the point is that egg quality and
quantity tends to decline significantly in the late 30s
and faster in the early 40s, but egg quantity and
quality in an individual woman can be average for
her age, better than average, or worse than average.
Therefore the age – related decline of the success in
IVF is largely attributable to a progressive decline of
ovarian oocyte quality and quantity. Woman's age is
an independent factor determining the success of
assisted reproductive technology treatment (35, 36).
Many infertility doctors recommend to women
over 38 that are infertile should have aggressive
treatment and proceed to IVF relatively quickly –
before all fertility potential is lost.
In summary, the postponement of marriage and
bearing the first child, the transition still underway
toward nontraditional family forms and unfavorable
economic and institutional factors explain a consider-
able part of the increase in levels of infertility so
marriage in early ages is a good way to prevent infer-
tility.
The main conclusion of the present review can be
summarized below points:
? Fertility declines significantly with increasing
age
? Age – related infertility is due to oocyte abnor-
malities
? Miscarriage rates are higher for older women.
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